Suppr超能文献

[通过中耳离子导入法给予新诺地卡酮治疗耳鸣]

[Treatment of tinnitus by Neolidocatone administered by iontophoresis into the middle ear].

作者信息

Sejna I, Marik E

机构信息

Otolaryngologická klinika ILF, Praha.

出版信息

Cesk Otolaryngol. 1990 Aug;39(4):221-4.

PMID:2289244
Abstract

The authors describe a possible therapeutic approach mitigating tinnitus. It is not causal treatment but only symptomatic and extends the group of methods which influence tinnitus. The authors describe their own experience with iontophoresis of the middle ear with Neolidocatone-a derivate of Lidocaine which was done with a SANOMATIC apparatus, using galvanic current 1.5 mA. In one third of the patients it proved possible to mitigate the tinnitus permanently, in the remaining patients it persisted in the original intensity. The group of patients was heterogeneous from idiopathic tinnitus without impaired hearing, patients with otosclerosis, cervicocranial syndrome to those with Ménière's disease. The cause of tinnitus did not influence the therapeutic results.

摘要

作者描述了一种减轻耳鸣的可能治疗方法。这不是病因治疗,而只是对症治疗,并且扩展了影响耳鸣的方法类别。作者描述了他们使用SANOMATIC仪器,通过1.5毫安直流电进行中耳离子导入新利多卡托宁(利多卡因的衍生物)的自身经验。三分之一的患者耳鸣被证实可以永久减轻,其余患者耳鸣仍维持原来的强度。患者群体各异,包括无听力受损的特发性耳鸣患者、耳硬化症患者、颈颅综合征患者以及梅尼埃病患者。耳鸣的病因不影响治疗效果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验